^“High-density genetic map of the BRCA1 region of chromosome 17q12-q21”. Genomics17 (3): 618–23. (September 1993). doi:10.1006/geno.1993.1381. PMID8244378.
^“Acute promyelocytic leukemia: new issues on pathogenesis and treatment response”. The International Journal of Biochemistry & Cell Biology39 (6): 1063–70. (2007). doi:10.1016/j.biocel.2007.01.028. PMID17468032.
^“Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells”. The Journal of Biological Chemistry273 (27): 16985–92. (July 1998). doi:10.1074/jbc.273.27.16985. PMID9642262.
^ ab“Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock”. Cell105 (7): 877–89. (June 2001). doi:10.1016/S0092-8674(01)00401-9. PMID11439184.
^“Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II”. The Journal of Biological Chemistry278 (8): 6355–62. (February 2003). doi:10.1074/jbc.M210697200. PMID12482873.
^“Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2”. Molecular Endocrinology15 (2): 241–54. (February 2001). doi:10.1210/mend.15.2.0595. PMID11158331.
^“A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo”. The Journal of Biological Chemistry274 (48): 34283–93. (November 1999). doi:10.1074/jbc.274.48.34283. PMID10567404.
^“Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein”. The Journal of Biological Chemistry274 (22): 15901–7. (May 1999). doi:10.1074/jbc.274.22.15901. PMID10336495.
^“Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia”. Blood91 (8): 2634–42. (April 1998). doi:10.1182/blood.V91.8.2634.2634_2634_2642. PMID9531570.
^“Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways”. Blood99 (8): 2637–46. (April 2002). doi:10.1182/blood.V99.8.2637. PMID11929748.
^“Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation”. The Journal of Biological Chemistry279 (1): 319–25. (January 2004). doi:10.1074/jbc.M307621200. PMID14581481.
^“Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity”. Biochemistry42 (4): 971–9. (February 2003). doi:10.1021/bi020497k. PMID12549917.
^“Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)”. Molecular Endocrinology12 (10): 1551–7. (October 1998). doi:10.1210/mend.12.10.0184. PMID9773978.
^“A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1”. Genes & Development9 (7): 769–82. (April 1995). doi:10.1101/gad.9.7.769. PMID7705655.
^“A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins”. Nature Genetics23 (3): 287–95. (November 1999). doi:10.1038/15463. PMID10610177.
“A human retinoic acid receptor which belongs to the family of nuclear receptors”. Nature330 (6147): 444–50. (1988). doi:10.1038/330444a0. PMID2825025.
“Molecular pathogenesis of acute promyelocytic leukaemia and APL variants”. Best Practice & Research. Clinical Haematology16 (3): 387–408. (September 2003). doi:10.1016/S1521-6926(03)00062-8. PMID12935958.
“Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin”. The Journal of Biological Chemistry269 (32): 20629–35. (August 1994). doi:10.1016/S0021-9258(17)32039-2. PMID8051161.
“Biosynthesis and function of all-trans- and 9-cis-retinoic acid in parathyroid cells”. Biochemical and Biophysical Research Communications229 (3): 922–9. (December 1996). doi:10.1006/bbrc.1996.1903. PMID9005841.
“Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1”. The Journal of Biological Chemistry272 (18): 12062–8. (May 1997). doi:10.1074/jbc.272.18.12062. PMID9115274.